Lorcaserin Extended-Release Tablets and Secukinumab Subcutaneous
Determining the interaction of Lorcaserin Extended-Release Tablets and Secukinumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: secukinumab
Brand name: Cosentyx, Cosentyx Sensoready Pen
Synonyms: Secukinumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Secura Antifungal
- Lorcaserin Extended-Release Tablets-Secura Antifungal Extra Thick
- Lorcaserin Extended-Release Tablets-Secura Antifungal Topical
- Lorcaserin Extended-Release Tablets-Seebri
- Lorcaserin Extended-Release Tablets-Seebri Neohaler
- Lorcaserin Extended-Release Tablets-Seebri Neohaler inhalation
- Secukinumab Subcutaneous-Lorcaserin Hydrochloride
- Secukinumab Subcutaneous-Lorcaserin Tablets
- Secukinumab Subcutaneous-Lorcet
- Secukinumab Subcutaneous-Lorcet Plus
- Secukinumab Subcutaneous-Lorcet Tablets
- Secukinumab Subcutaneous-Lorlatinib